Structure activity relationships of lysophospholipid mediators

Prostaglandins and Other Lipid Mediators

Volumn 64, Issue 1-4, 2001, Pages 33-45

  Lyncha, Kevin R ^a   MacDonald, Timothy L ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; G PROTEIN COUPLED RECEPTOR; LIGAND; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; PHOSPHATASE; RECEPTOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSYLPHOSPHORYLCHOLINE;

ARTICLE; BLOOD PRESSURE; CELL LINE; CHEMICAL STRUCTURE; DEPOLARIZATION; HUMAN; MOLECULAR CLONING; NONHUMAN; OOCYTE; PHARMACOPHORE; PROTEIN BINDING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE ACTIVATION; XENOPUS;

DRUG INDUSTRY; LYSOPHOSPHOLIPIDS; PHOSPHORYLCHOLINE; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 0035016044     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(01)00106-X     Document Type: Article

References (53)

1. Berger A., Bittman R., Schmidt R.R., Spiegel S. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity. Mol Pharmacol. 50:1996;451.
2. Lee M.-J., van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., et al. Sphingosine 1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science. 279:1998;1552.
3. Kon J., Sato K., Watanabe T., Tomura H., Kuwabara A., Kimura T., et al. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected chinese hamster ovary cells. J Biol Chem. 274:1999;23940.
4. 2+ mobilization, ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J Biol Chem. 273:1998;27104.
5. Im D.-S., Heise C.E., Ancellin N., O'Dowd B.F., Shei G-j, Heavens R.P., et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem. 275:2000;14281.
6. Ancellin N., Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3 and EDG-5. J Biol Chem. 274:1999;18997.
7. Okamoto H., Takuwa N., Yatomi Y., Gonda K., Shigematsu H., Takuwa Y. G3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. Biochem Biophys Res Comm. 260:1999;203.
8. van Brocklyn J.R., Gräler M.H., Bernhardt G., Lipp M., Spiegel S. Sphingosine 1-phosphate is a ligand for the G protein-coupled receptor Edg-6. Blood. 95:2000;2624.
9. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem. 273:1998;23722.
10. Kupperman E., An S., Osborne N., Waldron S., Stainier D.Y.R. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature. 406:2000;192.
11. Mandala S.M., Thornton R., Galve-Roperh I., Poulton S., Peterson C., Olivera A., et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine 1-phosphate and induces cell death. Proc Natl Acad Sci USA. 2000.
12. Sugiura T., Nakane S., Kishimoto S., Waku K., Yoshioka Y., Tokumura A., et al. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochim Biophys Acta. 1440:1999;194.
13. Xu Y., Gaudette D.C., Boynton J.D., Frankel A., Fang X.-J., Sharma A., et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res. 1:1995;1223.
14. Liliom K., Guan Z., Tseng J.-L., Desiderio D.M., Tigyi G., Watsky M.A. Growth factor-like phospholipids generated after corneal injury. Am J Physiol. 274:1998;C1065.
15. 2+ mobilization in human A431 cells structure-activity analysis . Biochem J. 307:1995;609.
16. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate induced cell proliferation identification and dissection of signaling pathways mediated by G proteins . Cell. 59:1989;45.
17. Tokumura A., Fukuzawa K., Tsukatani H. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids. 13:1978;572.
18. Tokumura A., Fukuzawa K., Yamada S., Tsukatani H. Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregnant rats. Arch Int Pharmacodyn. 245:1980;74.
19. Schumacher K.A., Classen H.G., Späth M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives identity with substances in aged serum (DAS) . Thromb Haemost. 42:1979;631.
20. Tokumura A., Kume T., Fukuzawa K., Tsukatani H. Cardiovascular effects of lysophosphatidic acid and its structural analogs in rats. J Pharmacol Exp Therap. 219:1981;219.
21. Watson S.P., McConnell R.T., Lapetina E.G. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action; evidence against a second messenger role for lysophosphatidic acid. Biochem J. 232:1985;61.
22. Gueguen G., Gaige B., Grevy J.-M., Rogalle P., Bellan J., Wilson M., et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry. 38:1999;8440.
23. Simon M.-F., Chap H., Douste-Blazy L. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs a new group of phospholipid mediators? Biochem Biophys Res Commun. 108:1982;1743.
24. Sugiura T., Tokumura A., Gregory L., Nouchi T., Weintraub S.T., Hanahan D.J. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets comparison with platelet activating factor . Arch Biochem Biophys. 311:1994;358.
25. Ferguson J.E., Hanley M.R. Phosphatidic acid and lysophosphatidic acid stimulate receptor-regulated membrane currents in the Xenopus laevis oocyte. Arch Biochem Biophys. 297:1992;388.
26. Tigyi G., Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem. 267:1992;21360.
27. Hargrave P.A., McDowell J.H. Rhodopsin and phototransduction a model system for G protein-linked receptors . FASEB J. 6:1992;2323.
28. Fernhout B.J.H., Dijcks F.A., Moolenaar W.H., Ruigt G.S.F. Lysophosphatidic acid induces inward currents in Xenopus laevis oocytes evidence for an extracellular site of action . Eur J Pharmacol. 213:1992;313.
29. Liliom K., Bittman R., Swords B., Tigyi G. N-Palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors. Mol Pharmacol. 50:1996;616.
30. Durieux M.E., Carlisle S.J., Salafranca M.N., Lynch K.R. Endogenous responses to sphingosine-1-phosphate in X. laevis oocytes similarities with lysophosphatidic acid signaling . Am J Physiol. 264:1993;C1360.
31. Liliom K., Fischer D.J., Virag T., Sun G., Miller D.D., Tseng J.-L., et al. Identification of a novel growth factor-like lipid, 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations. J Biol Chem. 273:1998;13461.
32. i-mediating inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate. Mol Pharmacol. 39:1991;740.
33. Lynch K.R., Hopper D.W., Carlisle S.J., Catalano J.G., Zhang M., Macdonald T.L. Structure-activity relationships in lysophosphatidic acid the 2-hydroxyl moiety . Mol Pharmacol. 52:1997;75.
34. Hopper D.W., Ragan S.P., Hooks S.B., Lynch K.R., Macdonald T.L. Structure-activity relationships of lysophosphatidic acid conformationally restricted backbone mimetics . J Med Chem. 42:1999;963.
35. Hooks S.B., Ragan S.P., Hopper D.W., Hönemann C.W., Durieux M.E., Macdonald T.L., et al. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic. Mol Pharmacol. 53:1998;188.
36. Zondag G.C.M., Postma F.R., van Etten I., Verlaan I., Moolenaar W.H. Sphingosine 1-phosphate signaling through the G-protein-coupled receptor Edg-1. Biochem J. 330:1998;605.
37. Bandoh K., Aoki J., Hosono H., Kobayashi S., Kobayashi T., Murakami-Murofushi K., et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem. 274:1999;27776.
38. Fukushima N., Kimura Y., Chun J. A single receptor encoded by vzg-1/lpa1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc Natl Acad Sci USA. 95:1998;6151.
39. Im D.-S., Heise C.E., Harding M.A., George S.R., O'Dowd B.F., Theodorescu D., et al. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol. 57:2000;753.
40. McAllister G., Stanton J.A., Salim K., Handford E.J., Beer M.S. Edg2 receptor functionality Giα1 co-expression and fusion protein studies . Mol Pharmacol. 58:2000;407.
41. van Rhee A.M., Jacobson K.A. Molecular architecture of G protein-coupled receptors. Drug Dev Res. 37:1996;1.
42. Parrill AL, Wang D-a, Bautista DL, van Brocklyn JR, Lorincz Z, Fischer DJ, et al. Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate. J Biol Chem (in press, ms # M007680200).
43. Brindley D.N., Waggoner D.W. Mammalian lipid phosphate phosphohydrolase. J Biol Chem. 273:1998;24281.
44. Hooks S.B., Ragan S.P., Lynch K.R. Identification of a novel phosphatidic acid phosphatase type 2 isoform. FEBS Lett. 427:1998;188.
45. Xu J., Love L.M., Singh I., Zhang Q.-X., Dewald J., Wang D.-A., et al. Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through Edg-2 receptors. J Biol Chem. 275:2000;. (in press).
46. Kai M., Wada I., Imai S.-I., Sakane F., Kanoh H. Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. J Biol Chem. 271:1996;18931.
47. 2+-independent phosphatidic acid phosphatase. J Biol Chem. 272:1997;24572.
48. 2+-independant phosphatidate phosphatase (PAP2) displays diacylglycerol pyrophosphate phosphatase activity. J Biol Chem. 272:1997;10361.
49. Xu Y., Zhu K., Hong G., Wu W., Baudhuin L.M., Xiao Y.-J., et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nature Cell Biol. 2:2000;261.
50. Bünemann M., Liliom K., Brandts B.K., Pott L., Tseng J.-L., Desiderio D.M., et al. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine-1-phosphate in atrial myocytes. EMBO J. 15:1996;5527.
51. Goth A., Adams H.R., Knoohuizen M. Phosphatidylserine selective enhancer of histamine release . Science. 173:1971;1034.
52. Horigome K., Tamori-Natori Y., Inoue K., Nojima S. Effect of serine phospholipid structure on the enhancement of concanavalin A-induced degranulation in rat mast cells. J Biochem. 100:1986;571.
53. Chang H.W., Inoue K., Bruni A., Boarato E., Toffano G. Stereoselective effects of lysophosphatidylserine in rodents. Br J Pharmacol. 93:1988;647.